Jared Berberabe[email protected]Pathology, histologySelf-supervised deep learning algorithm shows promise for rapid whole-slide-imaging retrievalBrigham and Women’s Hospital researchers are developing an algorithm to speed whole-slide-imaging retrieval from large digital repositories.October 19, 2022Heart DiseaseAI-enabled retina imaging could predict cardiovascular disease, deathThe method could enable the development of a noninvasive test to screen people who are at medium-to-high risk of circulatory disease.October 14, 2022SequencingUCLA researchers developing cfDNA blood test for early cancer detectionThe approach has the potential to provide a more than twelvefold cost-savings over conventional methods used to sequence the cfDNA methylome.October 4, 2022InfectiousCOVID-19 escalates risk for type 1 diabetes: Norway studyThe study, conducted by the Norwegian Institute of Public Health (NIPH) in Oslo, Norway, used national health registers to examine new-onset type 1 diabetes diagnoses in all youngsters under 18 in Norway (more than 1.2 million individuals) over the course of two years.September 26, 2022ValidationReading blood-oxygen saturation levels on a smartphoneIn the study, University of Washington and University of California San Diego researchers demonstrated that the use of a smartphone camera and flash could enable detection of blood oxygen saturation levels comparable to those measured in a clinic using a pulse oximeter clipped to a finger.September 20, 2022COVID-19Rapid antigen tests detect SARS-CoV-2 variants: NIH studyThe Emory University researchers who conducted the study used a method called deep mutational scanning (DMS) to simultaneously evaluate how any single amino acid substitution in the nucleocapsid (N) protein SARS-CoV-2 could affect diagnostic antibody binding.September 19, 2022Pathology, histologyWearable device measures tumor size changes under the skinThe device may provide an inexpensive and hands-free way to evaluate the efficacy of cancer drugs and could lead to promising new directions in cancer treatment, its developers said.September 15, 2022CE markQiagen developing, releasing assays for NeuMoDx systemThe assays, which permit the identification and quantification of the Epstein-Barr virus (EBV) and human herpesvirus 6 (HHV-6), have received CE-IVD certification for use in countries in the European Union and other countries that accept the CE Mark, Qiagen said.September 15, 2022COVID-19N-antigen levels point to COVID severity in NIH studyThe study by researchers at the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) was a cross-sectional follow-up analysis involving 2,540 participants who had been previously enrolled in the Therapeutics for Inpatients with COVID-19 (TICO) platform trial.September 8, 2022Artificial IntelligenceUsing the human voice to detect COVID, COPDPresenting their findings on Monday at the European Respiratory Society International Congress in Barcelona, Spain, Maastricht University researchers told the congress that their AI model was accurate 89% of the time and was more accurate than lateral flow rapid antigen tests.September 7, 2022Previous PagePage 2 of 3Next PageTop StoriesFDA ClearanceBioMérieux gets FDA 510(k) clearance, CLIA waiver approval for panelBioMérieux's Biofire Spotfire Respiratory/Sore Throat Panel has received dual FDA 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval.Mergers & AcquisitionsLabcorp acquires BioReference Health assetsSkin CancerCastle Biosciences shares melanoma test study data at SSO 2024Artificial IntelligenceIbex presents new study data for AI-powered cancer diagnostics platformEmerging TechnologyEventually, an oral cancer diagnosis may be a lick away